Vis enkel innførsel

dc.contributor.authorFrønsdal, Katrine Ben
dc.contributor.authorFacey, Karenen
dc.contributor.authorKlemp, Marianneen
dc.contributor.authorNorderhaug, Inger Natvigen
dc.contributor.authorMørland, Beriten
dc.contributor.authorRøttingen, John-Arneen
dc.date.accessioned2010-09-09T09:55:18Znb_NO
dc.date.accessioned2016-02-08T14:19:54Z
dc.date.available2010-09-09T09:55:18Znb_NO
dc.date.available2016-02-08T14:19:54Z
dc.date.issued2010-07nb_NO
dc.identifier.citationInternational journal of technology assessment in health care 2010, 26 (3):309-16en
dc.identifier.issn1471-6348nb_NO
dc.identifier.urihttp://hdl.handle.net/11250/2377956
dc.description.abstractBACKGROUND: The way in which a health technology is used in any particular health system depends on the decisions and actions of a variety of stakeholders, the local culture, and context. In 2009, the HTAi Policy Forum considered how health technology assessment (HTA) could be improved to optimize the use of technologies (in terms of uptake, change in use, or disinvestment) in such complex systems. METHODS: In scoping, it was agreed to focus on initiatives to implement evidence-based guidance and monitoring activities. A review identified systematic reviews of implementation initiatives and monitoring activities. A two-day deliberative workshop was held to discuss key papers, members' experiences, and collectively address key questions. This consensus paper was developed by email and finalized at a postworkshop meeting. RESULTS: Evidence suggests that the impact and use of HTA could be increased by ensuring timely delivery of relevant reports to clearly determined policy receptor (decision-making) points. To achieve this, the breadth of assessment, implementation initiatives such as incentives and targeted, intelligent dissemination of HTA result, needs to be considered. HTA stakeholders undertake a variety of monitoring activities, which could inform optimal use of a technology. However, the quality of these data varies and is often not submitted to an HTA. CONCLUSIONS: Monitoring data should be sufficiently robust so that they can be used in HTA to inform optimal use of technology. Evidence-based implementation initiatives should be developed for HTA, to better inform decision makers at all levels in a health system about the optimal use of technology.en
dc.language.isoengen
dc.publisherCambridge University Pressen
dc.relation.urihttp://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=7819819en
dc.subjectVDP::Medisinske Fag: 700::Helsefag: 800::Helsetjeneste- og helseadministrasjonsforskning: 806en
dc.subject.meshTechnology Assessment, Biomedicalen
dc.subject.meshHealth Services Researchen
dc.subject.meshHealth Policyen
dc.subject.meshDecision Makingen
dc.subject.meshEvidence Based Medicineen
dc.titleHealth technology assessment to optimize health technology utilization: using implementation initiatives and monitoring processes.en
dc.typeJournal articleen
dc.typePeer revieweden
dc.source.journalInternational journal of technology assessment in health careen
dc.identifier.doi10.1017/S0266462310000309nb_NO
dc.identifier.pmid20584360nb_NO
dc.contributor.departmentNorwegian Knowledge Centre for the Health Services, Oslo, Norway. kbf@nokc.noen


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel